©The Author(s) 2026.
World J Cardiol. Jan 26, 2026; 18(1): 111736
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111736
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111736
Table 1 Demographic characteristics, comorbidities, atherosclerotic disease, and chronic therapy, n (%)
| Variable | Occluded artery (n = 1687, 67.9%) | Patent artery (n = 796, 32.1%) | P value |
| Age (years) | 63 (55-73) | 66.3 (58-75) | < 0.0001 |
| Male sex | 1206 (72.9) | 572 (71.87) | 0.584 |
| Comorbidities | |||
| Atrial fibrillation | 95 (5.7) | 65 (8.2) | 0.018 |
| Arterial hypertension | 1176 (71.1) | 624 (78.4) | < 0.0001 |
| Diabetes mellitus | 346 (20.9) | 236 (29.6) | < 0.0001 |
| Family history of CV diseases | 545 (33.0) | 280 (35.2) | 0.649 |
| Smoking | 676 (40.6) | 278 (34.9) | < 0.001 |
| BMI (kg/m2) | 27.8 (25.3-30.9) | 27.8 (25.0-30.5) | 0.388 |
| Extent of atherosclerotic disease | |||
| Carotid stenosis | 60 (3.6) | 54 (6.8) | < 0.0001 |
| Peripheral artery disease | 89 (5.4) | 66 (8.3) | < 0.005 |
| Previous CABG | 26 (1.6) | 14 (1.8) | 0.735 |
| Previous PCI | 140 (8.5) | 89 (11.2) | 0.030 |
| Previous MI | 166 (10.0) | 117 (14.7) | < 0.0001 |
| Previous stroke | 83 (5.0) | 46 (5.8) | 0.427 |
| Chronic therapy (> 4 weeks before AMI) | |||
| ASA | 269 (16.3) | 178 (22.4) | < 0.0001 |
| ACEi/ARB | 618 (37.4) | 335 (22.1) | 0.005 |
| Beta-blockers | 372 (22.5) | 225 (28.3) | < 0.0001 |
| Statins | 255 (15.4) | 174 (21.9) | < 0.0001 |
- Citation: Kos N, Zeljković I, Golubic K, Radeljic V, Erceg M, Delic-Brkljacic D, Cigrovski Berkovic M, Bulj N. Impact of total occlusion of the infarct-related coronary artery on mortality of 2483 patients with acute myocardial infarction. World J Cardiol 2026; 18(1): 111736
- URL: https://www.wjgnet.com/1949-8462/full/v18/i1/111736.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i1.111736